These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8182013)

  • 1. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium.
    Mobarakai N; Landman D; Quale JM
    J Antimicrob Chemother; 1994 Feb; 33(2):319-21. PubMed ID: 8182013
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci.
    Khardori N; Gandhi M; Adame J; Kalvakuntla L; Rosenbaum B; Bodey GP
    J Antimicrob Chemother; 1990 May; 25(5):777-85. PubMed ID: 2142683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
    Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
    Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
    Johnson CC; Wendeler M; Levison ME
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1597-9. PubMed ID: 2145801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of trospectomycin against enterococci isolated from blood and other clinical materials.
    Watanakunakorn C
    J Antimicrob Chemother; 1991 Jun; 27(6):873-5. PubMed ID: 1834622
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1989 Apr; 33(4):569-72. PubMed ID: 2524997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of trospectomycin against methicillin-resistant Staphylococcus aureus and enterococci.
    Flournoy DJ; Koester JF
    Methods Find Exp Clin Pharmacol; 1992; 14(6):483-4. PubMed ID: 1469958
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
    Vogt K; Rodloff AC; Hahn H
    Infection; 1991; 19(3):138-9. PubMed ID: 1832417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    Zaman MM; Landman D; Burney S; Quale JM
    J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of synergy between vancomycin and trospectomycin against enterococci isolated from blood cultures.
    Watanakunakorn C
    J Antimicrob Chemother; 1992 Apr; 29(4):470-1. PubMed ID: 1535071
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro activity of trospectomycin against anaerobic bacteria.
    Chisari G; Lo Bue AM; Nicoletti G
    J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins.
    Dharuman S; Phelps GA; Dunn CM; Wilt LA; Murphy PA; Lee RB; Snoke HE; Selchow P; Haldimann K; Böttger EC; Hobbie SN; Sander P; Lee RE
    J Antibiot (Tokyo); 2024 Sep; 77(9):577-588. PubMed ID: 38890386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant Enterococcus faecium in a patient with burns.
    Min SS; Weber DJ; Donovan BJ; Gilligan PH; Cairns BA; Doern GV; Rutala WA
    Clin Infect Dis; 2003 May; 36(9):1210-1. PubMed ID: 12715325
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
    LiPuma JJ; Daley B; Stull TL
    J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals.
    Butaye P; Devriese LA; Haesebrouck F
    Antimicrob Agents Chemother; 2001 May; 45(5):1374-8. PubMed ID: 11302798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel plasmid-borne multidrug resistance gene cluster including lsa(E) from a linezolid-resistant Enterococcus faecium isolate of swine origin.
    Si H; Zhang WJ; Chu S; Wang XM; Dai L; Hua X; Dong Z; Schwarz S; Liu S
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7113-6. PubMed ID: 26324271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms.
    Holmberg A; Rasmussen M
    Int J Antimicrob Agents; 2014 Jul; 44(1):78-80. PubMed ID: 24837415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.